According to the results of economical and clinical evaluation of CMS, it was found that CMS exhibits the provision to be serving a consequent improvement in the quality of life and functional outcomes of the patients with back pain.

Back pain is the most common musculoskeletal condition with high cost of management. It is associated with functional limitation, depression, and anxiety, and thus reduced the quality of life (QoL).

An observational cohort study was conducted by comprising patient-reported outcome measures and existing administrative health database. Patients were referred into CMS for about three months and managed under common pathways. Outcome evaluation involved PSFS and EQ‐5D‐5L. Assessments were taken at baseline and repeated at the point at which the client's case was closed. The CARE measure examined patient-reported practicality. Cost Consequence evaluation was completed using existing data for the same period in two separate years: 2014, two years after CMS application, and 2011, prior Case Management Service development. There was a consequent statistical development in the quality of life (EQ‐5D‐5L p < 0.0001; EQ‐VAS p < 0.001) and functional capability (p < 0.001) succeeding the Physiotherapy Case Management. The CARE determination showed high levels of patient satisfaction with 96% of clients rating their case manager as good to excellent. The cost consequences evaluation showed a cost reduction in therapy resource utilization by £252 842 (from £10 772 875 to £10 520 034). All together,  service users are highly satisfied with their experience with the efficient use of resources.